Published 2014 | Version v1
Book

Role of natural antioxidant mediated cellular radiation response

  • 1. Chemical Radioprotector and Radiation Dosimetry Research Group, Institute of Nuclear Medicine and Allied Sciences, Delhi (India)
  • 2. Department of Biotechnology, Hamdard University, New Delhi (India)
  • 3. Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak (India)

Description

Need for the development of radioprotector was felt after witnessing the disastrous effects of ionizing radiation since World War II. Ionizing radiation is fatal for all living beings. Formation of free radicals (reactive oxygen species) are believed to be the prime reason for various cellular and molecular damages and death of cells. Different chemical agents having ability to quench these free radicals were selected logically for the development of radiation counter measure agents. WR2712 is the first FDA approved clinical cytoprotector, however acute toxicity necessitated search of safe chemical radiation countermeasure agents. Natural antioxidants possess strong antiradical properties and relatively less toxic and therefore currently persuaded for development of radioprotector. The objectives were to undertake a comprehensive mechanism based selection of suitable natural antioxidant compounds and evaluate their antiradical properties using standard assays. Further, validation of the radioprotective efficacy of selected antioxidant in vitro models and investigation in cell lines for elucidation of mechanism underlying radioprotection. Results of modified antiradical assays (ABTS, DPPH, ORAC and FRAP) suggested strong potential of sesamol in comparison to fifteen different antioxidants. Further comparative in vitro studies, prior treatment of antioxidant showed strong potential of sesamol with dose modifying factors of 10 (plasmid DNA) and 3 (V79 cells). The corresponding dose modifying factor of melatonin was 5 and 1.3 respectively. Furthermore, sesamol decreased radiation induced apoptosis, chromosomal aberration, cell cycle arrest, oxidative damages, mitochondrial depolarization in HEK293 cells. The mechanism of radioprotection proposed to be due to enhanced antioxidant enzyme activity and balance in cellular redox together with scavenging of free radicals by sesamol. Due to these potential of sesamol, further evaluation in preclinical models are required for development of radioprotector. (author)

Part of:
Proceedings of the international conference on radiation biology: frontiers in radiobiology - immunomodulation, countermeasures and therapeutics: abstract book, souvenir and scientific programme

Additional details

Publishing Information

Publisher
Institute of Nuclear Medicine and Allied Sciences
Imprint Place
Delhi (India)
Imprint Title
Proceedings of the international conference on radiation biology: frontiers in radiobiology - immunomodulation, countermeasures and therapeutics: abstract book, souvenir and scientific programme
Imprint Pagination
314 p.
Journal Page Range
p. 109

Conference

Title
international conference on radiation biology: frontiers in radiobiology - immunomodulation, countermeasures and therapeutics
Acronym
ICRB-2014
Dates
11-13 Nov 2014
Place
New Delhi (India)

INIS

Country of Publication
India
Country of Input or Organization
India
INIS RN
46095492
Subject category
S63: RADIATION, THERMAL, AND OTHER ENVIRONMENTAL POLLUTANT EFFECTS ON LIVING ORGANISMS AND BIOLOGICAL MATERIALS;
Resource subtype / Literary indicator
Conference
Descriptors DEI
APOPTOSIS; CHROMOSOMAL ABERRATIONS; CLINICAL TRIALS; DNA DAMAGES; RADIOPROTECTIVE SUBSTANCES; TOXICITY
Descriptors DEC
DRUGS; MUTATIONS; RESPONSE MODIFYING FACTORS; TESTING

Optional Information